2026 Eastern States Conference

Authors: Jennifer Gronski PharmD; Alyssa Robertson, PharmD, BCPS, BCCCP, BCEMP; Matthew Walbrown PharmD
Learning objective: Identify common etomidate doses used by physicians for rapid sequence intubation and procedural sedation.
Self-Assessment Question: True or False, the most common dose of etomidate used for rapid sequence intubation is 0.3 mg/kg.
Background/Objective: Etomidate is a short acting anesthetic agent used for rapid sequence intubation and procedural sedation with lack of literature showing which etomidate dose is preferred for each. The hypothesis of this survey is that there will be variability in dosing of etomidate.
Methods: This is a national survey that will be sent out through WellSpan York Hospital Emergency Medicine residency program alumni network, emergency medicine director network, and emergency medicine residency program director networks for physicians to complete. This survey aims to obtain information including hospital geographic location, trauma center designation, and annual emergency department volume. There are also questions about etomidate such as indication, dosing, adverse events, type of body weight used, dose-capping practices, and adjunctive therapy. The survey will be open for responses for four weeks, with all responses being included for analysis at the time of survey closure. 
Results: To be determined 
Conclusion: To be determined